Janos Fillinger
Budapest, BU, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Immune-related markers define clinically relevant prognostic subgroups in thymic epithelial tumors.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 26, 2026
A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinoma.
Journal: medRxiv : the preprint server for health sciences
Published: February 06, 2026
Development of experimental isolated lung perfusion model using surgically resected tumorous human lobes.
Journal: BMC pulmonary medicine
Published: January 13, 2026
A Subphase-Labeled Mitotic Dataset for AI-powered Cell Division Analysis.
Journal: Scientific data
Published: July 28, 2025
Spatial imaging features derived from SUVmax location in resectable NSCLC are associated with tumor aggressiveness.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 28, 2025
Using 18F-FDG PET/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 05, 2025
Impact of KRAS mutation subtypes on morphological heterogeneity and immune landscape in surgically treated lung adenocarcinoma.
Journal: Translational lung cancer research
Published: November 15, 2024
Diagnostic and prognostic relevance of inflammatory markers in surgically treated thymic epithelial tumors: An international multicenter study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 20, 2024
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma.
Journal: Nature cancer
Published: January 31, 2024
Last Updated: 09/26/2026